4//SEC Filing
O'KEEFE SHARON 4
Accession 0001251769-23-000028
CIK 0001251769other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:56 PM ET
Size
6.1 KB
Accession
0001251769-23-000028
Insider Transaction Report
Form 4
O'KEEFE SHARON
Director
Transactions
- Disposition to Issuer
Common Stock
2023-04-04−35,604→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 29, 2022, among the Issuer, Boston Scientific Corporation ("Parent") and Textile Merger Sub, Inc., an indirect wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger between Issuer and Merger Sub on April 4, 2023 (the "Merger"), at the effective time of the Merger (the "Effective Time"), each outstanding restricted stock unit award granted under any Issuer Stock Plan (each, an "Issuer RSU"), whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (1) the right to receive $10.00 in cash, without interest (the "Merger Consideration"), less applicable taxes and authorized deduction [footnote continues in footnote 2 below]
- [F2]and (2) the aggregate number of shares of Issuer common stock, par value $0.001 per share ("Issuer Common Stock") underlying such Issuer RSU, less applicable taxes and authorized deductions.
Documents
Issuer
Apollo Endosurgery, Inc.
CIK 0001251769
Entity typeother
Related Parties
1- filerCIK 0001544333
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:56 PM ET
- Size
- 6.1 KB